Kolin et al. (2020) found a wide variety of SMARCA4 inactivating mutations among the 12 cases of undifferentiated uterine sarcomas studied: one loss-of-function inversion and different frameshift, nonsense, missense, and splice site mutations. Here, SMARCA4 is linked to uterine corpus sarcoma.